A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction
Erectile dysfunction (ED) affects up to 50% of men between the ages of 40 and 70. Treatment with PDE-5 inhibitors is effective in the majority of men with ED. However, PDE-5 inhibitors are not effective when levels of nitric oxide (NO), the principle mediator of erection, are low. The pharmacologic...
Saved in:
Main Authors: | George F. Lasker, Jason H. Maley, Philip J. Kadowitz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Advances in Pharmacological Sciences |
Online Access: | http://dx.doi.org/10.1155/2010/730861 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of Priapism Secondary to Drugs for Erectile Dysfunction
by: José Pablo Saffon Cuartas, et al.
Published: (2019-01-01) -
Incontinence and Erectile Dysfunction Following Radical Prostatectomy: A Review
by: Gerasimos Alivizatos, et al.
Published: (2005-01-01) -
Erectile dysfunction: assessment and management in primary care
by: Yingxian Natalie Ong, et al.
Published: (2024-03-01) -
Erectile Dysfunction: Just a Difficulty of the Sex Organs?
by: Teresa Rodríguez Rodríguez
Published: (2017-07-01) -
The prevalence of sexual dysfunction and erectile dysfunction in men with multiple sclerosis: A systematic review and meta-analysis
by: V. Shaygannejad, et al.
Published: (2025-01-01)